Accounting Manager, R&D (Non-Clinical)

About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Overview of Role: The Accounting Manager, R&D (Non-Clinical) plays a critical, hands-on role in owning and managing R&D accruals and expense accounting for non-clinical trial activities across a global footprint (U.S., Europe, China). This role is central to ensuring R&D expenses are accurately accrued, analyzed, and supported, with close collaboration across vendors, internal project managers, and cross functional teams. This position requires a hands-on accounting leader who goes beyond transactional accounting to critically assess R&D activity and ensure accruals accurately represent the business. Working cross functionally with R&D, vendors, and project stakeholders across the U.S., Europe, and China, this role plays a key part in supporting global audits and statutory financial reporting in a dynamic, high growth environment. Role and Responsibilities: Own the end-to-end R&D accrual and expense accounting process for nonclinical activities, ensuring costs are accurately captured and reflect underlying business activity Prepare and review monthly journal entries and account reconciliations, exercising judgment to assess completeness, accuracy, and overall reasonableness Partner closely with vendors, internal project managers, and cross functional R&D teams to obtain data, validate assumptions, and support accrual calculations Support R&D cost areas including manufacturing, patient safety, biostatistics, CMC, supply chain, and non-trial clinical operations expenses Play a key role in the monthly close process, contributing to continuous improvement, documentation, and close efficiency Support global audits and statutory financial statements across the U.S., UK, and Switzerland by preparing schedules, analyses, and audit support Contribute to internal controls, SOX readiness, and accounting process development as the company continues to scale Ad-hoc tasks as assigned All other duties as assigned Experience, Education and Specialized Knowledge and Skills: Bachelor’s degree in Accounting, Finance, Business, related field A minimum of 5+ years of experience in accounting or finance with demonstrated ownership of accruals Hands‑on experience with R&D accruals in a biotech or pharmaceutical setting, including familiarity with complex R&D cost structure Demonstrated ability to apply judgment, evaluate assumptions, and assess the reasonableness of accruals in situations where inputs are incomplete or evolving Experience working cross functionally to interpret activity, resolve issues, and ensure accurate financial outcomes Exposure to global accounting environments, including supporting audits and statutory reporting across multiple jurisdictions Working knowledge of internal controls and close processes, with experience helping build, refine, and improve accounting practices in a growing organization Strong organizational skills, attention to detail, and the ability to operate effectively in a fastmoving, high growth setting Experience with NetSuite, close management and reconciliation tools (e.g., FloQast), and contract management systems (e.g., Agiloft) preferred Proficiency with the Microsoft Office Suite (Excel, Word, etc) This is the pay for this position Pay Transparency $140,000 — $160,000 USD Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation. Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at [email protected] to obtain prior written authorization before referring any candidates to Summit. Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

{
  "content_hash": "55c139ea0d37ca0d90007d4b767759a1fb8452a4b4d2aa7e71ef316a715d628b",
  "source_hash": "de2267d01d3051920b62b40a31f3008ef03a00f26043ba904d4c09ee640a307e",
  "last_changed_at": "2026-05-29T23:02:37.049Z",
  "active_status": "active"
}

{
  "language": "en",
  "location": {
    "raw": "Palo Alto, CA (US)",
    "city": "Palo Alto",
    "region": null,
    "country": "United States",
    "is_remote": true,
    "confidence": 0.95
  },
  "salary_max": null,
  "salary_min": null,
  "inferred_at": "2026-06-06T07:34:44.890Z",
  "launch_scope": {
    "reason": "english_us_canada",
    "included": true,
    "language": "en",
    "location": {
      "raw": "Palo Alto, CA (US)",
      "city": "Palo Alto",
      "region": null,
      "country": "United States",
      "is_remote": true,
      "confidence": 0.95
    },
    "countries": [
      "United States"
    ]
  },
  "remote_policy": "remote",
  "salary_period": null,
  "workplace_type": "remote",
  "salary_currency": null
}

{}

{
  "title": "Accounting Manager, R&D (Non-Clinical)",
  "offices": [
    {
      "id": 4024035009,
      "name": "Palo Alto, CA",
      "location": "Palo Alto, California, United States",
      "child_ids": [],
      "parent_id": null
    },
    {
      "id": 4024036009,
      "name": "Remote",
      "location": null,
      "child_ids": [],
      "parent_id": null
    }
  ],
  "language": "en",
  "location": {
    "name": "Palo Alto, CA (US)"
  },
  "metadata": [
    {
      "id": 6369593009,
      "name": "Hiring Manager",
      "value": "David Chiorelo",
      "value_type": "long_text"
    },
    {
      "id": 7106916009,
      "name": "FADV_Account",
      "value": "445997_SUMMIT THERAPEUTICS INC",
      "value_type": "single_select"
    },
    {
      "id": 7106917009,
      "name": "FADV_Package",
      "value": "2113_Summit Standard+Credit",
      "value_type": "single_select"
    }
  ],
  "updated_at": "2026-05-25T10:36:00-04:00",
  "departments": [
    {
      "id": 4025491009,
      "name": "Accounting",
      "child_ids": [],
      "parent_id": null
    }
  ],
  "company_name": "Summit Therapeutics",
  "requisition_id": 4101068009,
  "first_published": "2026-03-09T11:59:00-04:00",
  "application_deadline": null
}